Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT02886858
Eligibility Criteria:
Inclusion Criteria:
* 18-75 ans
* Remission (MADRS \<10) of a major depressive episode after acute treatment with ECT + venlafaxine
* Lithium adjunction 48h after the last ECT session
* No comorbid psychiatric disorder, excluding personality disorder or nicotine dependance.
* Capacity to consent
* Sufficient comprehension of the French language
Exclusion Criteria:
* Contra-indications to tDCS
* Neurologic conditions
* Severe medical conditions.
* Pregnancy/breast-feeding.
* Current use of benzodiazepines or antipsychotics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02886858
Study Brief:
Protocol Section:
NCT02886858